About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in New York | 136 Studies

Clinical Trials HypertensionNew York

Hypertension Clinical Trials in New York

Find 136 clinical trials for hypertension near New York, New York. Connect with research centers in your area.

All Hypertension trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 136 trials

Active not recruitingThe BD Liverty™ TIPS Stent Graft StudyThe objective of the study is to assess the safety and effectiveness of the BD Liverty™ TIPS Stent Graft for the treatment of the complications of portal hypertension from…NCT05711316·Palo Alto, California and 25 others Completed18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA)Study to collect effectiveness and safety data after administration of a bimatoprost intracameral implant in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).NCT04647214·Culver City, California and 38 others

Hypertension Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedNailfold Capillary Blood Flow With Latanoprost BunodThe purpose of this study is to look at the relationship of small blood vessels irregularities observed with an imaging system called video nailfold capillaroscopy in people with…NCT03949244·New York, New York

CompletedPROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)To demonstrate that Telmisartan combined with Hydrochlorothiazide (MICARDIS® HCT) is superior to Losartan with Hydrochlorothiazide (Hyzaar®) in lowering blood pressure in…NCT00274638·Huntsville, Alabama and 68 others

CompletedA Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)The purpose of this study is to evaluate the blood pressure (BP)-lowering efficacy of tonlamarsen in adult participants who, despite taking 2 or more antihypertensive medications…NCT06864104·Anniston, Alabama and 38 others

CompletedReducing Risk of RecurrenceAdults who have had a previous stroke or transient ischemic attack (TIA) remain at risk for having a second serious event, especially if they have uncontrolled blood pressure or…NCT01122394·New York, New York

CompletedNew York City (NYC) Health eHearts Pay for Quality PilotDo monetary incentives in small independent primary care practices improve the delivery of preventive services as recommended by U.S. Preventive Services Task Force (USPSTF)…NCT00884013·New York, New York

CompletedEndoscopic Ultrasound-Guided Portosystemic Pressure Gradient MeasurementsThe objective of the study is to collect and report technical success of direct endoscopic ultrasound guided hepatic and portal vein pressure measurement obtained with EchoTip®…NCT04668664·Orange, California and 6 others

TerminatedClinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAHPhase 3, placebo controlled, double-blind, randomized clinical study to determine safety, tolerability, and efficacy of pulsed, inhaled nitric oxide (iNO) versus placebo in…NCT02725372·Phoenix, Arizona and 108 others

RecruitingZilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseThe purpose of this study is to evaluate whether zilebesiran versus placebo reduces the risk of cardiovascular (CV) death, nonfatal myocardial infarction (MI), nonfatal stroke, or…NCT07181109·Birmingham, Alabama and 1152 others

Active not recruitingA Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)TX000045-003 is a double-blind, randomized, parallel group, placebo-controlled, proof- of-concept (POC) study, evaluating 2 dose regimens of TX000045 over the course of a 24-week…NCT06616974·Phoenix, Arizona and 71 others

RecruitingGlobal Paradise System US Post Approval StudyThe objective of the Global Paradise® System US Post Approval Study (US GPS) is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for…NCT06297291·Long Beach, California and 42 others

TerminatedOptic Nerve Head Structural Response to IOP Elevation in Patients With KeratoconusThe mechanism by which vision loss in glaucoma occurs is still unknown, but it is clear that increased Intraocular Pressure (IOP) is a major risk factor.NCT03560609·New York, New York

UnknownA Compassionate Case Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Glaucoma Patients With Uncontrolled Intraocular Pressure to Avoid Surgical InterventionA.NCT02174991·New York, New York

RecruitingEVE TRIAL , ALMA SYSTAMabnormal bleeding after childbirth. This condition is called abnormal bleeding and becomes a condition known as postpartum hemorrhage (PPH) when worsens.NCT06646653·Brooklyn, New York and 1 other

TerminatedThe "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 SettingA Comparison of Safety and Inhalation Times of Ventavis (iloprost) Inhalation Solution delivered by I-Neb Utilizing Power Disc-6 and Power Disc-15 "Power 15 Study"NCT00467896·Phoenix, Arizona and 11 others

CompletedA Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or GlaucomaGlaucoma is the world's the second leading cause of irreversible blindness.NCT01936389·New York, New York

TerminatedSafety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAHThe purpose of this 8-week study is to compare the effects of switching from intravenous Flolan to intravenous Remodulin therapy.NCT00439946·San Francisco, California and 2 others

CompletedAqueSys XEN 45 Glaucoma Implant in Refractory GlaucomaTo establish the safety and performance of the AqueSys XEN 45 Glaucoma Implant in eyes with refractory glaucoma.NCT02036541·Glendale, Arizona and 11 others

CompletedChronic Hypertension and Pregnancy (CHAP) ProjectThe purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age…NCT02299414·Birmingham, Alabama and 71 others

PreviousPage 5 of 7Next

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia